Congress creates diabetes oversight board to cut through federal silos
H.R. 9149 — National Diabetes Project Act · Filed by John James (R-MI) · Introduced Jun 4, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill establishes a National Diabetes Project within the Department of Health and Human Services to create a coordinated federal strategy for diabetes prevention, research, and care. It creates an advisory council with federal and non-federal experts to evaluate existing diabetes programs, recommend improvements, and produce annual reports to Congress on progress and priorities through 2036.
Why we flagged it
The bill's core function is establishing an interagency coordination mechanism and advisory structure for diabetes policy, not direct treatment or research funding. It is a governance and planning instrument designed to improve federal program alignment and transparency.
What the text implies
- The bill mandates data-sharing across federal agencies on diabetes, which could improve epidemiological understanding but also creates a centralized federal diabetes dataset that may raise privacy considerations if not carefully governed.
- By requiring evaluation of 'all federally funded efforts' and recommending programs be 'eliminated, coordinated, or condense[d],' the bill implicitly authorizes the Secretary to recommend consolidation or closure of existing programs, which could affect beneficiaries of smaller or redundant initiatives.
The full analysis lists 3 implications of this text.
Who stands to gain
pharmaceutical companies (diabetes treatment development); medical device manufacturers (diagnostic and monitoring equipment); healthcare providers and systems (coordinated care expansion)